|
 Gene ontology annotations for HSPA1A |
|
|
| Experiment description of studies that identified HSPA1A in sEVs |
| 1 |
| Experiment ID |
79 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD81|MHCII
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
20458337
|
| Organism |
Homo sapiens |
| Experiment description |
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis - Sample 1 |
| Authors |
"Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M, Stoorvogel W." |
| Journal name |
ICB
|
| Publication year |
2010 |
| Sample |
B cells |
| Sample name |
RN (HLA-DR15) |
| Isolation/purification methods |
Differential centrifugation
Sucrose density gradient
Immunobeads (MHC Class II) |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [FT-ICR]
Western blotting |
|
|
| 2 |
| Experiment ID |
80 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD81|MHCII
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
20458337
|
| Organism |
Homo sapiens |
| Experiment description |
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis -Sample 2 |
| Authors |
"Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M, Stoorvogel W." |
| Journal name |
ICB
|
| Publication year |
2010 |
| Sample |
B cells |
| Sample name |
RN (HLA-DR15) |
| Isolation/purification methods |
Differential centrifugation
Sucrose density gradient
Immunobeads (MHC Class II) |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [FT-ICR]
Western blotting |
|
|
| 3 |
| Experiment ID |
81 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD81|MHCII
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
20458337
|
| Organism |
Homo sapiens |
| Experiment description |
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis - Sample 3 |
| Authors |
"Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M, Stoorvogel W." |
| Journal name |
ICB
|
| Publication year |
2010 |
| Sample |
B cells |
| Sample name |
RN (HLA-DR15) |
| Isolation/purification methods |
Differential centrifugation
Sucrose density gradient
Immunobeads (MHC Class II) |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [FT-ICR]
Western blotting |
|
|
| 4 |
| Experiment ID |
76 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|GAPDH|HSP90|CD81|CD9|CD63|LAMP1|MHCI
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
20224111
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomics analysis of bladder cancer exosomes. |
| Authors |
"Welton JL, Khanna S, Giles PJ, Brennan P, Brewis IA, Staffurth J, Mason MD, Clayton A." |
| Journal name |
MCP
|
| Publication year |
2010 |
| Sample |
Bladder cancer cells |
| Sample name |
HT1376 |
| Isolation/purification methods |
Differential centrifugation
Sucrose density gradient |
| Flotation density |
1.10-1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [MALDI TOF/TOF]
Western blotting
FACS |
|
|
| 5 |
| Experiment ID |
489 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
|
✔
Canx
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
36408942
|
| Organism |
Rattus norvegicus |
| Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
| Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
| Journal name |
Proteomics
|
| Publication year |
2023 |
| Sample |
Bone marrow mesenchymal stem cells |
| Sample name |
BMSC - Passage 6 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectometry |
|
|
| 6 |
| Experiment ID |
490 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
|
✔
Canx
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
36408942
|
| Organism |
Rattus norvegicus |
| Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
| Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
| Journal name |
Proteomics
|
| Publication year |
2023 |
| Sample |
Bone marrow mesenchymal stem cells |
| Sample name |
BMSC - Passage 7 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectometry |
|
|
| 7 |
| Experiment ID |
491 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
|
✔
Canx
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
36408942
|
| Organism |
Rattus norvegicus |
| Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
| Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
| Journal name |
Proteomics
|
| Publication year |
2023 |
| Sample |
Bone marrow mesenchymal stem cells |
| Sample name |
BMSC - Passage 8 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectometry |
|
|
| 8 |
| Experiment ID |
492 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
|
✔
Canx
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
36408942
|
| Organism |
Rattus norvegicus |
| Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
| Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
| Journal name |
Proteomics
|
| Publication year |
2023 |
| Sample |
Bone marrow mesenchymal stem cells |
| Sample name |
BMSC - Passage 9 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectometry |
|
|
| 9 |
| Experiment ID |
522 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
FLOT1|CD9
|
Enriched markers |
|
✔
GOLGA2
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34112803
|
| Organism |
Homo sapiens |
| Experiment description |
Tumor microenvironmental cytokines bound to cancer exosomes determine uptake by cytokine receptor-expressing cells and biodistribution |
| Authors |
"Lima LG, Ham S, Shin H, Chai EPZ, Lek ESH, Lobb RJ, Müller AF, Mathivanan S, Yeo B, Choi Y, Parker BS, Möller A. " |
| Journal name |
Nat Commun
|
| Publication year |
2021 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Size exclusion chromatography
Centrifugal ultrafiltration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 10 |
| Experiment ID |
523 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
FLOT1|CD9
|
Enriched markers |
|
✔
GOLGA2
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34112803
|
| Organism |
Homo sapiens |
| Experiment description |
Tumor microenvironmental cytokines bound to cancer exosomes determine uptake by cytokine receptor-expressing cells and biodistribution |
| Authors |
"Lima LG, Ham S, Shin H, Chai EPZ, Lek ESH, Lobb RJ, Müller AF, Mathivanan S, Yeo B, Choi Y, Parker BS, Möller A. " |
| Journal name |
Nat Commun
|
| Publication year |
2021 |
| Sample |
Breast cancer cells |
| Sample name |
MCF7 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Size exclusion chromatography
Centrifugal ultrafiltration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 11 |
| Experiment ID |
527 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD9
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34112803
|
| Organism |
Mus musculus |
| Experiment description |
Tumor microenvironmental cytokines bound to cancer exosomes determine uptake by cytokine receptor-expressing cells and biodistribution |
| Authors |
"Lima LG, Ham S, Shin H, Chai EPZ, Lek ESH, Lobb RJ, Müller AF, Mathivanan S, Yeo B, Choi Y, Parker BS, Möller A. " |
| Journal name |
Nat Commun
|
| Publication year |
2021 |
| Sample |
Breast cancer cells |
| Sample name |
EO771 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Size exclusion chromatography
Centrifugal ultrafiltration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 12 |
| Experiment ID |
528 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD9
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34112803
|
| Organism |
Mus musculus |
| Experiment description |
Tumor microenvironmental cytokines bound to cancer exosomes determine uptake by cytokine receptor-expressing cells and biodistribution |
| Authors |
"Lima LG, Ham S, Shin H, Chai EPZ, Lek ESH, Lobb RJ, Müller AF, Mathivanan S, Yeo B, Choi Y, Parker BS, Möller A. " |
| Journal name |
Nat Commun
|
| Publication year |
2021 |
| Sample |
Breast cancer cells |
| Sample name |
EO771 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Size exclusion chromatography
Centrifugal ultrafiltration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 13 |
| Experiment ID |
529 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD9
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34112803
|
| Organism |
Mus musculus |
| Experiment description |
Tumor microenvironmental cytokines bound to cancer exosomes determine uptake by cytokine receptor-expressing cells and biodistribution |
| Authors |
"Lima LG, Ham S, Shin H, Chai EPZ, Lek ESH, Lobb RJ, Müller AF, Mathivanan S, Yeo B, Choi Y, Parker BS, Möller A. " |
| Journal name |
Nat Commun
|
| Publication year |
2021 |
| Sample |
Breast cancer cells |
| Sample name |
EO771 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Size exclusion chromatography
Centrifugal ultrafiltration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 14 |
| Experiment ID |
530 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34112803
|
| Organism |
Mus musculus |
| Experiment description |
Tumor microenvironmental cytokines bound to cancer exosomes determine uptake by cytokine receptor-expressing cells and biodistribution |
| Authors |
"Lima LG, Ham S, Shin H, Chai EPZ, Lek ESH, Lobb RJ, Müller AF, Mathivanan S, Yeo B, Choi Y, Parker BS, Möller A. " |
| Journal name |
Nat Commun
|
| Publication year |
2021 |
| Sample |
Breast cancer cells |
| Sample name |
EO771 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Size exclusion chromatography
Centrifugal ultrafiltration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 15 |
| Experiment ID |
924 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD9|SDCBP|CD81|RAB35|LAMP2|FLOT1|TSG101|CD63
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
30918259
|
| Organism |
Homo sapiens |
| Experiment description |
Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A |
| Authors |
"Im EJ, Lee CH, Moon PG, Rangaswamy GG, Lee B, Lee JM, Lee JC, Jee JG, Bae JS, Kwon TK, Kang KW, Jeong MS, Lee JE, Jung HS, Ro HJ, Jun S, Kang W, Seo SY, Cho YE, Song BJ, Baek MC." |
| Journal name |
Nat Commun
|
| Publication year |
2019 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 16 |
| Experiment ID |
927 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD9|SDCBP|CD81|RAB35|LAMP2|CD63
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
30918259
|
| Organism |
Homo sapiens |
| Experiment description |
Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A |
| Authors |
"Im EJ, Lee CH, Moon PG, Rangaswamy GG, Lee B, Lee JM, Lee JC, Jee JG, Bae JS, Kwon TK, Kang KW, Jeong MS, Lee JE, Jung HS, Ro HJ, Jun S, Kang W, Seo SY, Cho YE, Song BJ, Baek MC." |
| Journal name |
Nat Commun
|
| Publication year |
2019 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 17 |
| Experiment ID |
46 |
| MISEV standards |
|
✔
EM|IEM
|
Biophysical techniques |
|
✔
HSC70|CD63|MHCII|CD81|CD86
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
17641064
|
| Organism |
Homo sapiens |
| Experiment description |
Exosomes with immune modulatory features are present in human breast milk. |
| Authors |
"Admyre C, Johansson SM, Qazi KR, Filen JJ, Lahesmaa R, Norman M, Neve EP, Scheynius A, Gabrielsson S" |
| Journal name |
JIMMU
|
| Publication year |
2007 |
| Sample |
Breast milk |
| Sample name |
Breast milk - Colostrum |
| Isolation/purification methods |
Differential centrifugation
Filtration
Sucrose density gradient |
| Flotation density |
1.10-1.18 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QSTAR]
Western blotting
Immunoelectron Microscopy
FACS |
|
|
| 18 |
| Experiment ID |
1221 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|GAPDH
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
31054213
|
| Organism |
Homo sapiens |
| Experiment description |
Phosphoproteome Profiling of Isogenic Cancer Cell-Derived Exosome Reveals HSP90 as a Potential Marker for Human Cholangiocarcinoma |
| Authors |
"Weeraphan C, Phongdara A, Chaiyawat P, Diskul-Na-Ayudthaya P, Chokchaichamnankit D, Verathamjamras C, Netsirisawan P, Yingchutrakul Y, Roytrakul S, Champattanachai V, Svasti J, Srisomsap C." |
| Journal name |
Proteomics
|
| Publication year |
2019 |
| Sample |
Cholangiocarcinoma cells |
| Sample name |
KKU-M213 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Centrifugal ultrafiltration
Ultracentrifugation
Sucrose density gradient centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 19 |
| Experiment ID |
1222 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|GAPDH
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
31054213
|
| Organism |
Homo sapiens |
| Experiment description |
Phosphoproteome Profiling of Isogenic Cancer Cell-Derived Exosome Reveals HSP90 as a Potential Marker for Human Cholangiocarcinoma |
| Authors |
"Weeraphan C, Phongdara A, Chaiyawat P, Diskul-Na-Ayudthaya P, Chokchaichamnankit D, Verathamjamras C, Netsirisawan P, Yingchutrakul Y, Roytrakul S, Champattanachai V, Svasti J, Srisomsap C." |
| Journal name |
Proteomics
|
| Publication year |
2019 |
| Sample |
Cholangiocarcinoma cells |
| Sample name |
KKU-M213D5 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Centrifugal ultrafiltration
Ultracentrifugation
Sucrose density gradient centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 20 |
| Experiment ID |
20 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP90|CD63|CD81|LAMP1
|
Enriched markers |
|
✔
GOLGA2|cytochrome c
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
17956143
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of microvesicles derived from human colorectal cancer cells. |
| Authors |
"Choi DS, Lee JM, Park GW, Lim HW, Bang JY, Kim YK, Kwon KH, Kwon HJ, Kim KP, Gho YS" |
| Journal name |
JPR
|
| Publication year |
2007 |
| Sample |
Colorectal cancer cells |
| Sample name |
HT29 |
| Isolation/purification methods |
Differential centrifugation
Sucrose density gradient
Diafiltration |
| Flotation density |
1.16 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [LTQ]
Western blotting |
|
|
| 21 |
| Experiment ID |
21 |
| MISEV standards |
|
✔
EM|IEM
|
Biophysical techniques |
|
✔
Alix|TSG101|HSP70|CD63
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
19837982
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic and bioinformatic analysis of immunoaffinity-purified exosomes derived from the human colon tumor cell line LIM1215. |
| Authors |
"Suresh Mathivanan, Justin W.E. Lim, Bow J. Tauro, Hong Ji, Robert L. Moritz and Richard J. Simpson" |
| Journal name |
MCP
|
| Publication year |
2009 |
| Sample |
Colorectal cancer cells |
| Sample name |
LIM1215 |
| Isolation/purification methods |
Filtration
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.10-1.12 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [Orbitrap]
Western blotting |
|
|
| 22 |
| Experiment ID |
207 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
|
✔
VDAC
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
23161513
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
| Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
| Journal name |
Mol Cell Proteomics
|
| Publication year |
2012 |
| Sample |
Colorectal cancer cells |
| Sample name |
DKO-1 |
| Isolation/purification methods |
Differential centrifugation
Filtration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 23 |
| Experiment ID |
208 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
|
✔
VDAC
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
23161513
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
| Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
| Journal name |
Mol Cell Proteomics
|
| Publication year |
2012 |
| Sample |
Colorectal cancer cells |
| Sample name |
Dks-8 |
| Isolation/purification methods |
Differential centrifugation
Filtration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 24 |
| Experiment ID |
209 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
|
✔
VDAC
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
23161513
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
| Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
| Journal name |
Mol Cell Proteomics
|
| Publication year |
2012 |
| Sample |
Colorectal cancer cells |
| Sample name |
DLD-1 |
| Isolation/purification methods |
Differential centrifugation
Filtration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 25 |
| Experiment ID |
1203 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
SDCBP|FLOT1|CD9|CD81|CD63|EPCAM|GAPDH|LAMP1|TFRC|CD151|CD82|LAMP2|RAB35|TSG101|FLOT2|RAB5B|ICAM1|RAB5A
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34887515
|
| Organism |
Homo sapiens |
| Experiment description |
Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets |
| Authors |
"Zhang Q, Jeppesen DK, Higginbotham JN, Graves-Deal R, Trinh VQ, Ramirez MA, Sohn Y, Neininger AC, Taneja N, McKinley ET, Niitsu H, Cao Z, Evans R, Glass SE, Ray KC, Fissell WH, Hill S, Rose KL, Huh WJ, Washington MK, Ayers GD, Burnette DT, Sharma S, Rome LH, Franklin JL, Lee YA, Liu Q, Coffey RJ." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Colorectal cancer cells |
| Sample name |
DiFi |
| Isolation/purification methods |
Differential centrifugation
Filtration
Centrifugal ultrafiltration
Ultracentrifugation
OptiPrep density gradient centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein
miRNA |
| Methods used in the study |
Western blotting
Mass spectrometry
RNA sequencing |
|
|
| 26 |
| Experiment ID |
1361 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
TSG101|CD63|FLOT1|LAMP1|CD24|EPCAM|Alix
|
Enriched markers |
|
✔
HSP90AA1
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36303008
|
| Organism |
Homo sapiens |
| Experiment description |
A hydrogel-based mechanical metamaterial for the interferometric profiling of extracellular vesicles in patient samples |
| Authors |
"Zhao H, Pan S, Natalia A, Wu X, Ong CJ, Teo MCC, So JBY, Shao H." |
| Journal name |
Nat Biomed Eng
|
| Publication year |
2023 |
| Sample |
Colorectal cancer cells |
| Sample name |
HCT116 |
| Isolation/purification methods |
Filtration
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
MORPH
ELISA |
|
|
| 27 |
| Experiment ID |
234 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✔
qNano
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
26054723
|
| Organism |
Homo sapiens |
| Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
| Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
| Journal name |
Carcinogenesis
|
| Publication year |
2015 |
| Sample |
Hepatocellular carcinoma cells |
| Sample name |
HKCI-C3 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.13-1.19 g/mL
|
| Molecules identified in the study |
Protein
RNA |
| Methods used in the study |
Western blotting
Mass spectrometry
RT-PCR
RNA Sequencing |
|
|
| 28 |
| Experiment ID |
235 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✔
qNano
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
26054723
|
| Organism |
Homo sapiens |
| Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
| Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
| Journal name |
Carcinogenesis
|
| Publication year |
2015 |
| Sample |
Hepatocellular carcinoma cells |
| Sample name |
HKCI-8 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.13-1.19 g/mL
|
| Molecules identified in the study |
Protein
RNA |
| Methods used in the study |
Western blotting
Mass spectrometry
RT-PCR
RNA Sequencing |
|
|
| 29 |
| Experiment ID |
236 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✔
qNano
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
26054723
|
| Organism |
Homo sapiens |
| Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
| Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
| Journal name |
Carcinogenesis
|
| Publication year |
2015 |
| Sample |
Hepatocellular carcinoma cells |
| Sample name |
MHCC97L |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.13-1.19 g/mL
|
| Molecules identified in the study |
Protein
RNA |
| Methods used in the study |
Western blotting
Mass spectrometry
RT-PCR
RNA Sequencing |
|
|
| 30 |
| Experiment ID |
237 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✔
qNano
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
26054723
|
| Organism |
Homo sapiens |
| Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
| Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
| Journal name |
Carcinogenesis
|
| Publication year |
2015 |
| Sample |
Hepatocytes |
| Sample name |
MIHA |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.13-1.19 g/mL
|
| Molecules identified in the study |
Protein
RNA |
| Methods used in the study |
Western blotting
Mass spectrometry
RNA Sequencing |
|
|
| 31 |
| Experiment ID |
189 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✘
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
19530224
|
| Organism |
Homo sapiens |
| Experiment description |
Profile of exosomes related proteins released by differentiated and undifferentiated human keratinocytes. |
| Authors |
"Chavez-Muñoz C, Kilani RT, Ghahary A." |
| Journal name |
J Cell Physiol
|
| Publication year |
2009 |
| Sample |
Keratinocytes |
| Sample name |
Keratinocytes - Differentiated |
| Isolation/purification methods |
Differential centrifugation
Filtration
Sucrose cushion
Filtration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 32 |
| Experiment ID |
190 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSC70
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
19530224
|
| Organism |
Homo sapiens |
| Experiment description |
Profile of exosomes related proteins released by differentiated and undifferentiated human keratinocytes. |
| Authors |
"Chavez-Muñoz C, Kilani RT, Ghahary A." |
| Journal name |
J Cell Physiol
|
| Publication year |
2009 |
| Sample |
Keratinocytes |
| Sample name |
Keratinocytes - Undifferentiated |
| Isolation/purification methods |
Differential centrifugation
Filtration
Sucrose cushion
Filtration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 33 |
| Experiment ID |
691 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|CD63|TSG101|CD9|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Western blotting
|
| PubMed ID |
29335551
|
| Organism |
Homo sapiens |
| Experiment description |
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer |
| Authors |
"Fang T, Lv H, Lv G, Li T, Wang C, Han Q, Yu L, Su B, Guo L, Huang S, Cao D, Tang L, Tang S, Wu M, Yang W, Wang H." |
| Journal name |
Nat Commun
|
| Publication year |
2018 |
| Sample |
Liver cancer cells |
| Sample name |
CSQT-2 |
| Isolation/purification methods |
Filtration
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein
miRNA |
| Methods used in the study |
Western blotting
Microarray
qRT-PCR |
|
|
| 34 |
| Experiment ID |
692 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|CD63|TSG101|CD9|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Western blotting
|
| PubMed ID |
29335551
|
| Organism |
Homo sapiens |
| Experiment description |
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer |
| Authors |
"Fang T, Lv H, Lv G, Li T, Wang C, Han Q, Yu L, Su B, Guo L, Huang S, Cao D, Tang L, Tang S, Wu M, Yang W, Wang H." |
| Journal name |
Nat Commun
|
| Publication year |
2018 |
| Sample |
Liver cancer cells |
| Sample name |
HCC-LM3 |
| Isolation/purification methods |
Filtration
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein
miRNA |
| Methods used in the study |
Western blotting
Microarray
qRT-PCR |
|
|
| 35 |
| Experiment ID |
693 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|CD63|TSG101|CD9|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Western blotting
|
| PubMed ID |
29335551
|
| Organism |
Homo sapiens |
| Experiment description |
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer |
| Authors |
"Fang T, Lv H, Lv G, Li T, Wang C, Han Q, Yu L, Su B, Guo L, Huang S, Cao D, Tang L, Tang S, Wu M, Yang W, Wang H." |
| Journal name |
Nat Commun
|
| Publication year |
2018 |
| Sample |
Liver cancer cells |
| Sample name |
HepG2 |
| Isolation/purification methods |
Filtration
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein
miRNA |
| Methods used in the study |
Western blotting
Microarray
qRT-PCR |
|
|
| 36 |
| Experiment ID |
694 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|CD63|TSG101|CD9|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Western blotting
|
| PubMed ID |
29335551
|
| Organism |
Homo sapiens |
| Experiment description |
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer |
| Authors |
"Fang T, Lv H, Lv G, Li T, Wang C, Han Q, Yu L, Su B, Guo L, Huang S, Cao D, Tang L, Tang S, Wu M, Yang W, Wang H." |
| Journal name |
Nat Commun
|
| Publication year |
2018 |
| Sample |
Liver cancer cells |
| Sample name |
MHCC-97L |
| Isolation/purification methods |
Filtration
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein
miRNA |
| Methods used in the study |
Western blotting
Microarray
qRT-PCR |
|
|
| 37 |
| Experiment ID |
1371 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD81|CD63|CD9|TSG101|Alix
|
Enriched markers |
|
✘
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36631249
|
| Organism |
Homo sapiens |
| Experiment description |
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos |
| Authors |
"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, Tsui YM, Ma HT, Lee E, Chen A, Lee J, Wang Y, Yam JWP, Cheung TT, Guan X, Ng IO." |
| Journal name |
Gut
|
| Publication year |
2023 |
| Sample |
Liver cancer cells |
| Sample name |
PLC |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 38 |
| Experiment ID |
1372 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD81|CD63|CD9|TSG101|Alix
|
Enriched markers |
|
✘
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36631249
|
| Organism |
Homo sapiens |
| Experiment description |
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos |
| Authors |
"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, Tsui YM, Ma HT, Lee E, Chen A, Lee J, Wang Y, Yam JWP, Cheung TT, Guan X, Ng IO." |
| Journal name |
Gut
|
| Publication year |
2023 |
| Sample |
Liver cancer cells |
| Sample name |
PLC |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 39 |
| Experiment ID |
1373 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD81|CD63|CD9|TSG101|Alix
|
Enriched markers |
|
✘
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36631249
|
| Organism |
Homo sapiens |
| Experiment description |
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos |
| Authors |
"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, Tsui YM, Ma HT, Lee E, Chen A, Lee J, Wang Y, Yam JWP, Cheung TT, Guan X, Ng IO." |
| Journal name |
Gut
|
| Publication year |
2023 |
| Sample |
Liver cancer cells |
| Sample name |
97L |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 40 |
| Experiment ID |
1374 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD81|CD63|CD9|TSG101|Alix
|
Enriched markers |
|
✘
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36631249
|
| Organism |
Homo sapiens |
| Experiment description |
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos |
| Authors |
"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, Tsui YM, Ma HT, Lee E, Chen A, Lee J, Wang Y, Yam JWP, Cheung TT, Guan X, Ng IO." |
| Journal name |
Gut
|
| Publication year |
2023 |
| Sample |
Liver cancer cells |
| Sample name |
97L |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 41 |
| Experiment ID |
1375 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD81|CD63|CD9|TSG101|Alix
|
Enriched markers |
|
✘
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36631249
|
| Organism |
Homo sapiens |
| Experiment description |
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos |
| Authors |
"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, Tsui YM, Ma HT, Lee E, Chen A, Lee J, Wang Y, Yam JWP, Cheung TT, Guan X, Ng IO." |
| Journal name |
Gut
|
| Publication year |
2023 |
| Sample |
Liver cancer cells |
| Sample name |
MIHA |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 42 |
| Experiment ID |
1376 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD81|CD63|CD9|TSG101|Alix
|
Enriched markers |
|
✘
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36631249
|
| Organism |
Homo sapiens |
| Experiment description |
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos |
| Authors |
"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, Tsui YM, Ma HT, Lee E, Chen A, Lee J, Wang Y, Yam JWP, Cheung TT, Guan X, Ng IO." |
| Journal name |
Gut
|
| Publication year |
2023 |
| Sample |
Liver cancer cells |
| Sample name |
MIHA |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 43 |
| Experiment ID |
1377 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD81|CD63|CD9|TSG101|Alix
|
Enriched markers |
|
✘
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36631249
|
| Organism |
Homo sapiens |
| Experiment description |
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos |
| Authors |
"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, Tsui YM, Ma HT, Lee E, Chen A, Lee J, Wang Y, Yam JWP, Cheung TT, Guan X, Ng IO." |
| Journal name |
Gut
|
| Publication year |
2023 |
| Sample |
Liver cancer cells |
| Sample name |
97H |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 44 |
| Experiment ID |
1378 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD81|CD63|CD9|TSG101|Alix
|
Enriched markers |
|
✘
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36631249
|
| Organism |
Homo sapiens |
| Experiment description |
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos |
| Authors |
"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, Tsui YM, Ma HT, Lee E, Chen A, Lee J, Wang Y, Yam JWP, Cheung TT, Guan X, Ng IO." |
| Journal name |
Gut
|
| Publication year |
2023 |
| Sample |
Liver cancer cells |
| Sample name |
97H |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 45 |
| Experiment ID |
1381 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD63|CD81|TSG101|Alix
|
Enriched markers |
|
✘
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36631249
|
| Organism |
Homo sapiens |
| Experiment description |
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos |
| Authors |
"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, Tsui YM, Ma HT, Lee E, Chen A, Lee J, Wang Y, Yam JWP, Cheung TT, Guan X, Ng IO." |
| Journal name |
Gut
|
| Publication year |
2023 |
| Sample |
Liver cancer cells |
| Sample name |
97H |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 46 |
| Experiment ID |
1382 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD63|CD81|TSG101|Alix
|
Enriched markers |
|
✘
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36631249
|
| Organism |
Homo sapiens |
| Experiment description |
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos |
| Authors |
"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, Tsui YM, Ma HT, Lee E, Chen A, Lee J, Wang Y, Yam JWP, Cheung TT, Guan X, Ng IO." |
| Journal name |
Gut
|
| Publication year |
2023 |
| Sample |
Liver cancer cells |
| Sample name |
97H |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 47 |
| Experiment ID |
1383 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36631249
|
| Organism |
Homo sapiens |
| Experiment description |
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos |
| Authors |
"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, Tsui YM, Ma HT, Lee E, Chen A, Lee J, Wang Y, Yam JWP, Cheung TT, Guan X, Ng IO." |
| Journal name |
Gut
|
| Publication year |
2023 |
| Sample |
Liver cancer cells |
| Sample name |
97H |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 48 |
| Experiment ID |
1384 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36631249
|
| Organism |
Homo sapiens |
| Experiment description |
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos |
| Authors |
"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, Tsui YM, Ma HT, Lee E, Chen A, Lee J, Wang Y, Yam JWP, Cheung TT, Guan X, Ng IO." |
| Journal name |
Gut
|
| Publication year |
2023 |
| Sample |
Liver cancer cells |
| Sample name |
97H |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 49 |
| Experiment ID |
1385 |
| MISEV standards |
|
|
Biophysical techniques |
|
|
Enriched markers |
|
✘
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36631249
|
| Organism |
Homo sapiens |
| Experiment description |
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos |
| Authors |
"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, Tsui YM, Ma HT, Lee E, Chen A, Lee J, Wang Y, Yam JWP, Cheung TT, Guan X, Ng IO." |
| Journal name |
Gut
|
| Publication year |
2023 |
| Sample |
Liver cancer cells |
| Sample name |
PLC |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 50 |
| Experiment ID |
1386 |
| MISEV standards |
|
|
Biophysical techniques |
|
|
Enriched markers |
|
✘
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36631249
|
| Organism |
Homo sapiens |
| Experiment description |
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos |
| Authors |
"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, Tsui YM, Ma HT, Lee E, Chen A, Lee J, Wang Y, Yam JWP, Cheung TT, Guan X, Ng IO." |
| Journal name |
Gut
|
| Publication year |
2023 |
| Sample |
Liver cancer cells |
| Sample name |
PLC |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 51 |
| Experiment ID |
1387 |
| MISEV standards |
|
|
Biophysical techniques |
|
|
Enriched markers |
|
✘
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36631249
|
| Organism |
Homo sapiens |
| Experiment description |
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos |
| Authors |
"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, Tsui YM, Ma HT, Lee E, Chen A, Lee J, Wang Y, Yam JWP, Cheung TT, Guan X, Ng IO." |
| Journal name |
Gut
|
| Publication year |
2023 |
| Sample |
Liver cancer cells |
| Sample name |
PLC |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 52 |
| Experiment ID |
1388 |
| MISEV standards |
|
|
Biophysical techniques |
|
|
Enriched markers |
|
✘
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36631249
|
| Organism |
Homo sapiens |
| Experiment description |
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos |
| Authors |
"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, Tsui YM, Ma HT, Lee E, Chen A, Lee J, Wang Y, Yam JWP, Cheung TT, Guan X, Ng IO." |
| Journal name |
Gut
|
| Publication year |
2023 |
| Sample |
Liver cancer cells |
| Sample name |
PLC |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 53 |
| Experiment ID |
731 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|SDCBP
|
Enriched markers |
|
✔
GOLGA2|TUBA1A
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
35136055
|
| Organism |
Homo sapiens |
| Experiment description |
"Syntenin-1-mediated small extracellular vesicles promotes cell growth, migration, and angiogenesis by increasing onco-miRNAs secretion in lung cancer cells" |
| Authors |
"Kim O, Hwangbo C, Tran PT, Lee JH." |
| Journal name |
Cell Death Dis
|
| Publication year |
2022 |
| Sample |
Lung cancer cells |
| Sample name |
NCI-H226 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein
miRNA |
| Methods used in the study |
Western blotting
miRNA array |
|
|
| 54 |
| Experiment ID |
732 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|SDCBP
|
Enriched markers |
|
✔
GOLGA2|TUBA1A
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
35136055
|
| Organism |
Homo sapiens |
| Experiment description |
"Syntenin-1-mediated small extracellular vesicles promotes cell growth, migration, and angiogenesis by increasing onco-miRNAs secretion in lung cancer cells" |
| Authors |
"Kim O, Hwangbo C, Tran PT, Lee JH." |
| Journal name |
Cell Death Dis
|
| Publication year |
2022 |
| Sample |
Lung cancer cells |
| Sample name |
NCI-H226 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein
miRNA |
| Methods used in the study |
Western blotting
miRNA array |
|
|
| 55 |
| Experiment ID |
733 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|SDCBP
|
Enriched markers |
|
✔
TUBA1A
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
35136055
|
| Organism |
Homo sapiens |
| Experiment description |
"Syntenin-1-mediated small extracellular vesicles promotes cell growth, migration, and angiogenesis by increasing onco-miRNAs secretion in lung cancer cells" |
| Authors |
"Kim O, Hwangbo C, Tran PT, Lee JH." |
| Journal name |
Cell Death Dis
|
| Publication year |
2022 |
| Sample |
Lung cancer cells |
| Sample name |
BZR |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 56 |
| Experiment ID |
734 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
SDCBP
|
Enriched markers |
|
✔
TUBA1A
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
35136055
|
| Organism |
Homo sapiens |
| Experiment description |
"Syntenin-1-mediated small extracellular vesicles promotes cell growth, migration, and angiogenesis by increasing onco-miRNAs secretion in lung cancer cells" |
| Authors |
"Kim O, Hwangbo C, Tran PT, Lee JH." |
| Journal name |
Cell Death Dis
|
| Publication year |
2022 |
| Sample |
Lung cancer cells |
| Sample name |
BZR |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 57 |
| Experiment ID |
736 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|SDCBP
|
Enriched markers |
|
✔
TUBA1A
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
35136055
|
| Organism |
Homo sapiens |
| Experiment description |
"Syntenin-1-mediated small extracellular vesicles promotes cell growth, migration, and angiogenesis by increasing onco-miRNAs secretion in lung cancer cells" |
| Authors |
"Kim O, Hwangbo C, Tran PT, Lee JH." |
| Journal name |
Cell Death Dis
|
| Publication year |
2022 |
| Sample |
Lung cancer cells |
| Sample name |
A549 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein
miRNA |
| Methods used in the study |
Western blotting
RT-qPCR |
|
|
| 58 |
| Experiment ID |
1067 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|CD63|GAPDH
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34500436
|
| Organism |
Homo sapiens |
| Experiment description |
"MiR-185-5p targets RAB35 gene to regulate tumor cell-derived exosomes-mediated proliferation, migration and invasion of non-small cell lung cancer cells" |
| Authors |
"Wen H, Liu Z, Tang J, Bu L." |
| Journal name |
Aging
|
| Publication year |
2021 |
| Sample |
Lung cancer cells |
| Sample name |
A549 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 59 |
| Experiment ID |
1068 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|CD63|GAPDH
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34500436
|
| Organism |
Homo sapiens |
| Experiment description |
"MiR-185-5p targets RAB35 gene to regulate tumor cell-derived exosomes-mediated proliferation, migration and invasion of non-small cell lung cancer cells" |
| Authors |
"Wen H, Liu Z, Tang J, Bu L." |
| Journal name |
Aging
|
| Publication year |
2021 |
| Sample |
Lung cancer cells |
| Sample name |
A549 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 60 |
| Experiment ID |
1069 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|CD63|GAPDH
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34500436
|
| Organism |
Homo sapiens |
| Experiment description |
"MiR-185-5p targets RAB35 gene to regulate tumor cell-derived exosomes-mediated proliferation, migration and invasion of non-small cell lung cancer cells" |
| Authors |
"Wen H, Liu Z, Tang J, Bu L." |
| Journal name |
Aging
|
| Publication year |
2021 |
| Sample |
Lung cancer cells |
| Sample name |
A549 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 61 |
| Experiment ID |
1070 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|CD63|GAPDH
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34500436
|
| Organism |
Homo sapiens |
| Experiment description |
"MiR-185-5p targets RAB35 gene to regulate tumor cell-derived exosomes-mediated proliferation, migration and invasion of non-small cell lung cancer cells" |
| Authors |
"Wen H, Liu Z, Tang J, Bu L." |
| Journal name |
Aging
|
| Publication year |
2021 |
| Sample |
Lung cancer cells |
| Sample name |
A549 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 62 |
| Experiment ID |
1071 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|CD63|GAPDH
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34500436
|
| Organism |
Homo sapiens |
| Experiment description |
"MiR-185-5p targets RAB35 gene to regulate tumor cell-derived exosomes-mediated proliferation, migration and invasion of non-small cell lung cancer cells" |
| Authors |
"Wen H, Liu Z, Tang J, Bu L." |
| Journal name |
Aging
|
| Publication year |
2021 |
| Sample |
Lung cancer cells |
| Sample name |
A549 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 63 |
| Experiment ID |
1072 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|CD63|GAPDH
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34500436
|
| Organism |
Homo sapiens |
| Experiment description |
"MiR-185-5p targets RAB35 gene to regulate tumor cell-derived exosomes-mediated proliferation, migration and invasion of non-small cell lung cancer cells" |
| Authors |
"Wen H, Liu Z, Tang J, Bu L." |
| Journal name |
Aging
|
| Publication year |
2021 |
| Sample |
Lung cancer cells |
| Sample name |
H2170 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 64 |
| Experiment ID |
1073 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|CD63|GAPDH
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34500436
|
| Organism |
Homo sapiens |
| Experiment description |
"MiR-185-5p targets RAB35 gene to regulate tumor cell-derived exosomes-mediated proliferation, migration and invasion of non-small cell lung cancer cells" |
| Authors |
"Wen H, Liu Z, Tang J, Bu L." |
| Journal name |
Aging
|
| Publication year |
2021 |
| Sample |
Lung cancer cells |
| Sample name |
H2170 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 65 |
| Experiment ID |
1074 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|CD63|GAPDH
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34500436
|
| Organism |
Homo sapiens |
| Experiment description |
"MiR-185-5p targets RAB35 gene to regulate tumor cell-derived exosomes-mediated proliferation, migration and invasion of non-small cell lung cancer cells" |
| Authors |
"Wen H, Liu Z, Tang J, Bu L." |
| Journal name |
Aging
|
| Publication year |
2021 |
| Sample |
Lung cancer cells |
| Sample name |
H2170 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 66 |
| Experiment ID |
1075 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|CD63|GAPDH
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34500436
|
| Organism |
Homo sapiens |
| Experiment description |
"MiR-185-5p targets RAB35 gene to regulate tumor cell-derived exosomes-mediated proliferation, migration and invasion of non-small cell lung cancer cells" |
| Authors |
"Wen H, Liu Z, Tang J, Bu L." |
| Journal name |
Aging
|
| Publication year |
2021 |
| Sample |
Lung cancer cells |
| Sample name |
H2170 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 67 |
| Experiment ID |
1076 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|CD63|GAPDH
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34500436
|
| Organism |
Homo sapiens |
| Experiment description |
"MiR-185-5p targets RAB35 gene to regulate tumor cell-derived exosomes-mediated proliferation, migration and invasion of non-small cell lung cancer cells" |
| Authors |
"Wen H, Liu Z, Tang J, Bu L." |
| Journal name |
Aging
|
| Publication year |
2021 |
| Sample |
Lung cancer cells |
| Sample name |
H2170 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 68 |
| Experiment ID |
12 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
MHCI
|
Enriched markers |
|
✔
CANX|cytochrome c
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
15478216
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. |
| Authors |
"Mears R, Craven RA, Hanrahan S, Totty N, Upton C, Young SL, Patel P, Selby PJ, Banks RE" |
| Journal name |
PROTEOMICS
|
| Publication year |
2004 |
| Sample |
Melanoma cells |
| Sample name |
MeWo
SK-MEL-28 |
| Isolation/purification methods |
Filtration
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.13-1.20 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [4700 Proteomics Analyzer]
Western blotting |
|
|
| 69 |
| Experiment ID |
200 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|TSG101|Alix|GAPDH
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
22635005
|
| Organism |
Homo sapiens |
| Experiment description |
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. |
| Authors |
"Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, Garcia-Santos G, Ghajar C, Nitadori-Hoshino A, Hoffman C, Badal K, Garcia BA, Callahan MK, Yuan J, Martins VR, Skog J, Kaplan RN, Brady MS, Wolchok JD, Chapman PB, Kang Y, Bromberg J, Lyden D." |
| Journal name |
Nat Med
|
| Publication year |
2012 |
| Sample |
Melanoma cells |
| Sample name |
B16-F10
SK-MEL-202
SK-MEL035
SK-MEL-265 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Sucrose cushion |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 70 |
| Experiment ID |
254 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
MNT-1 |
| Isolation/purification methods |
Differential centrifugation
Unltracentrifugation
Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 71 |
| Experiment ID |
255 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
G1 |
| Isolation/purification methods |
Differential centrifugation
Unltracentrifugation
Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 72 |
| Experiment ID |
256 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
501mel |
| Isolation/purification methods |
Differential centrifugation
Unltracentrifugation
Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 73 |
| Experiment ID |
257 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
Daju |
| Isolation/purification methods |
Differential centrifugation
Unltracentrifugation
Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 74 |
| Experiment ID |
258 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
SKMEL28 |
| Isolation/purification methods |
Differential centrifugation
Unltracentrifugation
Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 75 |
| Experiment ID |
259 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
A375M |
| Isolation/purification methods |
Differential centrifugation
Unltracentrifugation
Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 76 |
| Experiment ID |
260 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
1205Lu |
| Isolation/purification methods |
Differential centrifugation
Unltracentrifugation
Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 77 |
| Experiment ID |
126 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
GAPDH
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry [LTQ-FT Ultra]
|
| PubMed ID |
Unpublished / Not applicable
|
| Organism |
Homo sapiens |
| Experiment description |
Mesenchymal Stem Cell Exosomes: The Future MSC-based Therapy? |
| Authors |
"Ruenn Chai Lai, Ronne Wee Yeh Yeo, Soon Sim Tan, Bin Zhang, Yijun Yin, Newman Siu Kwan Sze, Andre Choo, and Sai Kiang Lim" |
| Journal name |
Mesenchymal Stem Cell Therapy
|
| Publication year |
2011 |
| Sample |
Mesenchymal stem cells |
| Sample name |
huES9.E1 |
| Isolation/purification methods |
HPLC |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Antobody array
Mass spectrometry |
|
|
| 78 |
| Experiment ID |
488 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD9|CD81|CD63|GAPDH|SDCBP|LAMP1|TFRC|UCHL1|FLOT2|LAMP2|FLOT1|ICAM1|RAB5B|CD151|RAB35|TSG101|RAB5A|CD82
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
36408942
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
| Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
| Journal name |
Proteomics
|
| Publication year |
2023 |
| Sample |
Mesenchymal stem cells |
| Sample name |
UCMSC |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectometry |
|
|
| 79 |
| Experiment ID |
25 |
| MISEV standards |
|
✔
IEM
|
Biophysical techniques |
|
✔
HSP90|beta-tubulin
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
15111327
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes secreted by human mesothelioma cells. |
| Authors |
"Hegmans JP, Bard MP, Hemmes A, Luider TM, Kleijmeer MJ, Prins JB, Zitvogel L, Burgers SA, Hoogsteden HC, Lambrecht BN." |
| Journal name |
AJP
|
| Publication year |
2004 |
| Sample |
Mesothelioma cells |
| Sample name |
PMR-MM7
PMR-MM8 |
| Isolation/purification methods |
Differential centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [MALDI TOF]
Western blotting |
|
|
| 80 |
| Experiment ID |
224 |
| MISEV standards |
|
✔
EM|AFM
|
Biophysical techniques |
|
✔
Alix|TSG101|CD63|CD81
|
Enriched markers |
|
✔
GOLGA2
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25944692
|
| Organism |
Homo sapiens |
| Experiment description |
Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes |
| Authors |
"Keerthikumar S, Gangoda L, Liem M, Fonseka P, Atukorala I, Ozcitti C, Mechler A, Adda CG, Ang CS, Mathivanan S" |
| Journal name |
Oncotarget
|
| Publication year |
2015 |
| Sample |
Neuroblastoma cells |
| Sample name |
SH-SY5Y |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation
OptiPrep density gradient |
| Flotation density |
1.10 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry
Western blotting |
|
|
| 81 |
| Experiment ID |
211 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix|EpCAM|TFRC
|
Enriched markers |
|
✔
cytochrome c|GOLGA2
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
23333927
|
| Organism |
Homo sapiens |
| Experiment description |
Characterization and proteomic analysis of ovarian cancer-derived exosomes. |
| Authors |
"Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K." |
| Journal name |
J Proteomics
|
| Publication year |
2013 |
| Sample |
Ovarian cancer cells |
| Sample name |
IGROV1 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.09-1.15 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 82 |
| Experiment ID |
212 |
| MISEV standards |
|
✔
CEM
|
Biophysical techniques |
|
✔
TSG101|Alix|EpCAM|TFRC
|
Enriched markers |
|
✔
Cytochrome C|GOLGA2
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
23333927
|
| Organism |
Homo sapiens |
| Experiment description |
Characterization and proteomic analysis of ovarian cancer-derived exosomes. |
| Authors |
"Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K." |
| Journal name |
J Proteomics
|
| Publication year |
2013 |
| Sample |
Ovarian cancer cells |
| Sample name |
OVCAR-3 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.09-1.15 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 83 |
| Experiment ID |
524 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
FLOT1|CD9
|
Enriched markers |
|
✔
GOLGA2
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34112803
|
| Organism |
Homo sapiens |
| Experiment description |
Tumor microenvironmental cytokines bound to cancer exosomes determine uptake by cytokine receptor-expressing cells and biodistribution |
| Authors |
"Lima LG, Ham S, Shin H, Chai EPZ, Lek ESH, Lobb RJ, Müller AF, Mathivanan S, Yeo B, Choi Y, Parker BS, Möller A. " |
| Journal name |
Nat Commun
|
| Publication year |
2021 |
| Sample |
Plasma |
| Sample name |
Pooled plasma from healthy subjects and breast cancer patients |
| Isolation/purification methods |
Size exclusion chromatography
Centrifugal ultrafiltration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 84 |
| Experiment ID |
1369 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD63|CD81|CD9|TSG101|Alix
|
Enriched markers |
|
✘
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36631249
|
| Organism |
Homo sapiens |
| Experiment description |
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos |
| Authors |
"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, Tsui YM, Ma HT, Lee E, Chen A, Lee J, Wang Y, Yam JWP, Cheung TT, Guan X, Ng IO." |
| Journal name |
Gut
|
| Publication year |
2023 |
| Sample |
Plasma |
| Sample name |
Healthy donors |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 85 |
| Experiment ID |
1370 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD81|CD63|CD9|TSG101|Alix
|
Enriched markers |
|
✘
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36631249
|
| Organism |
Homo sapiens |
| Experiment description |
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos |
| Authors |
"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, Tsui YM, Ma HT, Lee E, Chen A, Lee J, Wang Y, Yam JWP, Cheung TT, Guan X, Ng IO." |
| Journal name |
Gut
|
| Publication year |
2023 |
| Sample |
Plasma |
| Sample name |
Hepatocellular carcinoma patients |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Immuno-EM |
|
|
| 86 |
| Experiment ID |
231 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
Alix|CD63|CD9
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25332113
|
| Organism |
Homo sapiens |
| Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
| Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
| Journal name |
Transfusion
|
| Publication year |
2015 |
| Sample |
Platelets |
| Sample name |
PL-Exs - Rep 1 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Optiprep density gradient |
| Flotation density |
1.12-1.15 g/mL
|
| Molecules identified in the study |
Protein
Lipids |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 87 |
| Experiment ID |
232 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✘
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25332113
|
| Organism |
Homo sapiens |
| Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
| Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
| Journal name |
Transfusion
|
| Publication year |
2015 |
| Sample |
Platelets |
| Sample name |
PL-Exs - Rep 2 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Optiprep density gradient |
| Flotation density |
1.12-1.15 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 88 |
| Experiment ID |
233 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✘
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25332113
|
| Organism |
Homo sapiens |
| Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
| Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
| Journal name |
Transfusion
|
| Publication year |
2015 |
| Sample |
Platelets |
| Sample name |
PL-Exs - Rep 3 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Optiprep density gradient |
| Flotation density |
1.12-1.15 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 89 |
| Experiment ID |
143 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
22723089
|
| Organism |
Homo sapiens |
| Experiment description |
Prostate cancer cell derived exosomes |
| Authors |
"Hosseini-Beheshti E, Guns ES." |
| Journal name |
MCP
|
| Publication year |
2012 |
| Sample |
Prostate cancer cells |
| Sample name |
LNCaP - Rep 3 |
| Isolation/purification methods |
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QTOF] |
|
|
| 90 |
| Experiment ID |
145 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|RAB5|CD10
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
22723089
|
| Organism |
Homo sapiens |
| Experiment description |
Prostate cancer cell derived exosomes |
| Authors |
"Hosseini-Beheshti E, Guns ES." |
| Journal name |
MCP
|
| Publication year |
2012 |
| Sample |
Prostate cancer cells |
| Sample name |
C4-2 - Rep 3 |
| Isolation/purification methods |
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QTOF] |
|
|
| 91 |
| Experiment ID |
66 |
| MISEV standards |
|
✔
IEM
|
Biophysical techniques |
|
✔
TSG101|Alix|CD63|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
19199708
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). |
| Authors |
"Gonzalez-Begne M, Lu B, Han X, Hagen FK, Hand AR, Melvin JE, Yates JR" |
| Journal name |
JPR
|
| Publication year |
2009 |
| Sample |
Saliva |
| Sample name |
Saliva |
| Isolation/purification methods |
Differential centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [LTQ]
Western blotting
Immunoelectron Microscopy |
|
|
| 92 |
| Experiment ID |
217 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|CD81|CD9|CD63
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
23844026
|
| Organism |
Homo sapiens |
| Experiment description |
Characterization of human thymic exosomes. |
| Authors |
"Skogberg G, Gudmundsdottir J, van der Post S, Sandstrom K, Bruhn S, Benson M, Mincheva-Nilsson L, Baranov V, Telemo E, Ekwall O." |
| Journal name |
PLoS One
|
| Publication year |
2013 |
| Sample |
Thymus |
| Sample name |
Normal-Thymus |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 93 |
| Experiment ID |
34 |
| MISEV standards |
|
✔
EM|IEM
|
Biophysical techniques |
|
✔
TSG101|CD63|MHCI|MHCII
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
19190083
|
| Organism |
Homo sapiens |
| Experiment description |
Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. |
| Authors |
"Kesimer M, Scull M, Brighton B, Demaria G, Burns K, O'Neal W, Pickles RJ, Sheehan JK" |
| Journal name |
FASEB
|
| Publication year |
2009 |
| Sample |
Tracheobronchial cells |
| Sample name |
Tracheobronchial epithelial cells |
| Isolation/purification methods |
Differential centrifugation
Filtration
Sucrose density gradient |
| Flotation density |
1.16 -1.18 g/mL
|
| Molecules identified in the study |
Protein
mRNA |
| Methods used in the study |
Mass spectrometry [QTOF]
Western blotting
Immunoelectron Microscopy
FACS |
|
|
| 94 |
| Experiment ID |
13 |
| MISEV standards |
|
✔
IEM
|
Biophysical techniques |
|
✔
Alix|RAB4|RAB5B|RAB11|TSG101|CD9|AQP2|AQP1
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
15326289
|
| Organism |
Homo sapiens |
| Experiment description |
Identification and proteomic profiling of exosomes in human urine. |
| Authors |
"Pisitkun T, Shen RF, Knepper MA" |
| Journal name |
PNAS
|
| Publication year |
2004 |
| Sample |
Urine |
| Sample name |
Urine - Normal |
| Isolation/purification methods |
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [LCQ DECA XP]
Western blotting |
|
|
| 95 |
| Experiment ID |
193 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD63|CD9
|
Enriched markers |
|
✔
PHB
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
21595033
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. |
| Authors |
"Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, Kwon TH, Kim CD, Park SH, Hwang D, Kim YL, Baek MC." |
| Journal name |
Proteomics
|
| Publication year |
2011 |
| Sample |
Urine |
| Sample name |
Urine - Normal |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 96 |
| Experiment ID |
194 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✘
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
21595033
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. |
| Authors |
"Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, Kwon TH, Kim CD, Park SH, Hwang D, Kim YL, Baek MC." |
| Journal name |
Proteomics
|
| Publication year |
2011 |
| Sample |
Urine |
| Sample name |
Urine - Patients of basement membrane nephropathy |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 97 |
| Experiment ID |
195 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✘
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
21595033
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. |
| Authors |
"Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, Kwon TH, Kim CD, Park SH, Hwang D, Kim YL, Baek MC." |
| Journal name |
Proteomics
|
| Publication year |
2011 |
| Sample |
Urine |
| Sample name |
Urine - Patients of early IgA nephropathy |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 98 |
| Experiment ID |
196 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
Alix|TSG101|HSP70|CD9
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
22418980
|
| Organism |
Homo sapiens |
| Experiment description |
A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes. |
| Authors |
"Raj DA, Fiume I, Capasso G, Pocsfalvi G." |
| Journal name |
Kidney Int
|
| Publication year |
2012 |
| Sample |
Urine |
| Sample name |
Urine - Normal high density |
| Isolation/purification methods |
Differential centrifugation
Sucrose cushion |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 99 |
| Experiment ID |
197 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
Alix|TSG101|HSP70|CD9
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
22418980
|
| Organism |
Homo sapiens |
| Experiment description |
A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes. |
| Authors |
"Raj DA, Fiume I, Capasso G, Pocsfalvi G." |
| Journal name |
Kidney Int
|
| Publication year |
2012 |
| Sample |
Urine |
| Sample name |
Urine - Normal low density |
| Isolation/purification methods |
Differential centrifugation
Sucrose cushion |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| Protein-protein interactions for HSPA1A |
| |
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
| 1 |
SPATS2 |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 2 |
DNAJC13 |
23317 |
| Proximity Label-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 3 |
GJD3 |
|
| Proximity Label-MS |
|
Homo sapiens |
|
| 4 |
ISG15 |
9636 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 5 |
UTRN |
7402 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 6 |
DGCR14 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 7 |
RALB |
5899 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 8 |
UBL4A |
8266 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 9 |
PACSIN1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 10 |
SHC1 |
6464 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 11 |
GUK1 |
2987 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 12 |
Mfn2 |
|
| Affinity Capture-Western |
|
Mus musculus |
|
| 13 |
PKM |
5315 |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 14 |
TSHZ2 |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 15 |
ZNF703 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 16 |
CAP1 |
10487 |
| Co-fractionation |
|
Homo sapiens |
|
| 17 |
DNAJB2 |
3300 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 18 |
EBNA-LP |
|
| Affinity Capture-Western |
|
|
|
| 19 |
GAK |
2580 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 20 |
MRPL45 |
84311 |
| Affinity Capture-Western |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
|
| 21 |
MAP4 |
4134 |
| Co-fractionation |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 22 |
UBE3A |
7337 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 23 |
VHL |
|
| Co-fractionation |
|
Homo sapiens |
|
| 24 |
LOC100132735 |
|
| Protein-RNA |
|
Homo sapiens |
|
| 25 |
RBM12 |
10137 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 26 |
RIPK1 |
8737 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 27 |
HDAC4 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 28 |
GCN1L1 |
10985 |
| Co-fractionation |
|
Homo sapiens |
|
| 29 |
RUFY1 |
80230 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 30 |
TCEB3 |
6924 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 31 |
MAP3K5 |
4217 |
| Affinity Capture-Western |
|
Homo sapiens |
| Reconstituted Complex |
|
Homo sapiens |
|
| 32 |
WDR76 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 33 |
PFKL |
5211 |
| Co-fractionation |
|
Homo sapiens |
|
| 34 |
PPP1CB |
5500 |
| Co-fractionation |
|
Homo sapiens |
|
| 35 |
UBE2O |
63893 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 36 |
MPP5 |
64398 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 37 |
C18orf25 |
147339 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 38 |
CCAR2 |
57805 |
| Co-fractionation |
|
Homo sapiens |
|
| 39 |
HDLBP |
3069 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 40 |
H2AFV |
94239 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 41 |
TRDN |
10345 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 42 |
NUDT3 |
11165 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 43 |
HSPH1 |
10808 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 44 |
LRRC48 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 45 |
PIK3C3 |
5289 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 46 |
RHOA |
387 |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 47 |
DNAJB1 |
3337 |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 48 |
GSPT1 |
2935 |
| Co-fractionation |
|
Homo sapiens |
|
| 49 |
KTN1 |
3895 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 50 |
FAF1 |
11124 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 51 |
HMG20B |
|
| Co-fractionation |
|
Homo sapiens |
|
| 52 |
NSFL1C |
55968 |
| Co-fractionation |
|
Homo sapiens |
|
| 53 |
RCOR3 |
|
| Co-fractionation |
|
Homo sapiens |
|
| 54 |
FOXP3 |
|
| Affinity Capture-Western |
|
Homo sapiens |
|
| 55 |
EEF1A1 |
1915 |
| Co-fractionation |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
|
| 56 |
PPIP5K2 |
23262 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 57 |
ATP1A3 |
478 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 58 |
HAT1 |
8520 |
| Co-fractionation |
|
Homo sapiens |
|
| 59 |
AGO2 |
27161 |
| Co-fractionation |
|
Homo sapiens |
|
| 60 |
HSPA9 |
3313 |
| Co-fractionation |
|
Homo sapiens |
|
| 61 |
BAG5 |
9529 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 62 |
AURKA |
6790 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 63 |
CARS |
833 |
| Co-fractionation |
|
Homo sapiens |
|
| 64 |
DIS3L |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 65 |
DBNL |
28988 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 66 |
WNK1 |
65125 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 67 |
TRIM7 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 68 |
CRY1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 69 |
CCDC176 |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 70 |
SAE1 |
10055 |
| Biochemical Activity |
|
Homo sapiens |
|
| 71 |
PPP6R2 |
9701 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 72 |
HIST1H2AG |
8969 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 73 |
C17orf49 |
124944 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 74 |
MAPRE1 |
22919 |
| Two-hybrid |
|
Homo sapiens |
|
| 75 |
DNAJB7 |
|
| Affinity Capture-Western |
|
Homo sapiens |
|
| 76 |
TUFM |
7284 |
| Co-fractionation |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 77 |
MRPS36 |
92259 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 78 |
PPP1R2 |
5504 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 79 |
ESRRB |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 80 |
PABPC1 |
26986 |
| Co-fractionation |
|
Homo sapiens |
|
| 81 |
CDH1 |
999 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 82 |
GALP |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 83 |
YWHAE |
7531 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 84 |
MYH9 |
4627 |
| Co-fractionation |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 85 |
IWS1 |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 86 |
ACTN4 |
81 |
| Co-fractionation |
|
Homo sapiens |
|
| 87 |
OGT |
8473 |
| Reconstituted Complex |
|
Homo sapiens |
|
| 88 |
OR10A4 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 89 |
ALKBH3 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 90 |
SYNCRIP |
10492 |
| Co-fractionation |
|
Homo sapiens |
|
| 91 |
PTK2 |
5747 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 92 |
FNBP1 |
23048 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 93 |
CUL2 |
8453 |
| Affinity Capture-MS |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
|
| 94 |
ACTC1 |
70 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 95 |
DDX39B |
7919 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 96 |
ANKRD44 |
91526 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 97 |
ADAMTS17 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 98 |
HSPB8 |
26353 |
| Co-localization |
|
Homo sapiens |
|
| 99 |
ID2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 100 |
ATXN1 |
6310 |
| Two-hybrid |
|
Homo sapiens |
|
| 101 |
PHLPP1 |
|
| Proximity Label-MS |
|
Homo sapiens |
|
| 102 |
DNAJB14 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 103 |
HSPA5 |
3309 |
| Co-fractionation |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 104 |
RBM39 |
9584 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 105 |
SMG7 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 106 |
NASP |
4678 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 107 |
BAG1 |
573 |
| Affinity Capture-MS |
|
Homo sapiens |
| Reconstituted Complex |
|
Homo sapiens |
|
| 108 |
YBX1 |
4904 |
| Co-fractionation |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
|
| 109 |
MAD1L1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 110 |
CUL3 |
8452 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
|
| 111 |
CCT8 |
10694 |
| Co-fractionation |
|
Homo sapiens |
|
| 112 |
EPRS |
2058 |
| Co-fractionation |
|
Homo sapiens |
|
| 113 |
FN1 |
2335 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 114 |
GUCY2D |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 115 |
TUBA4A |
7277 |
| Co-fractionation |
|
Homo sapiens |
|
| 116 |
Hsph1 |
15505 |
| Affinity Capture-MS |
|
Mus musculus |
|
| 117 |
PCBP1 |
5093 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 118 |
GNAS |
2778 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 119 |
SPEN |
23013 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 120 |
RPA3 |
6119 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 121 |
UBA52 |
7311 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 122 |
TMCO1 |
54499 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 123 |
CDC20 |
991 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 124 |
USP24 |
23358 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 125 |
HSPA1A |
3303 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 126 |
HSPA4 |
3308 |
| Affinity Capture-MS |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 127 |
PRPF40A |
55660 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 128 |
STMN1 |
3925 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 129 |
SGTA |
6449 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 130 |
CARHSP1 |
23589 |
| Co-fractionation |
|
Homo sapiens |
|
| 131 |
CSDE1 |
7812 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 132 |
RNF208 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 133 |
KCTD15 |
79047 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 134 |
MYH10 |
4628 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 135 |
NFATC2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 136 |
GRIP1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 137 |
PABPN1 |
8106 |
| Co-fractionation |
|
Homo sapiens |
|
| 138 |
PPP2CB |
5516 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 139 |
STUB1 |
10273 |
| Reconstituted Complex |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Biochemical Activity |
|
Homo sapiens |
| Reconstituted Complex |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Proximity Label-MS |
|
Homo sapiens |
| Protein-peptide |
|
Homo sapiens |
|
| 140 |
DDX46 |
9879 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 141 |
PSMB2 |
5690 |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 142 |
RELA |
5970 |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 143 |
FASN |
2194 |
| Co-fractionation |
|
Homo sapiens |
|
| 144 |
TUBGCP2 |
10844 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 145 |
BSDC1 |
55108 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 146 |
HSF1 |
|
| Affinity Capture-Western |
|
Homo sapiens |
| Reconstituted Complex |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
|
| 147 |
SIK2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 148 |
WWOX |
51741 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 149 |
EPCAM |
4072 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 150 |
MKL2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 151 |
CDC37 |
11140 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 152 |
TUBGCP3 |
10426 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 153 |
LCK |
3932 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 154 |
RMI1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 155 |
C9orf40 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 156 |
WDR35 |
57539 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 157 |
HSP90AA1 |
3320 |
| Reconstituted Complex |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 158 |
ARFIP2 |
23647 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 159 |
TARS |
6897 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 160 |
ZEB1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 161 |
DYNC1H1 |
1778 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 162 |
WWP2 |
11060 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 163 |
MAP1LC3A |
84557 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 164 |
COL24A1 |
255631 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 165 |
GAPDH |
2597 |
| Co-fractionation |
|
Homo sapiens |
|
| 166 |
BCL2 |
|
| Affinity Capture-Western |
|
Homo sapiens |
|
| 167 |
C3orf38 |
285237 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 168 |
SUPT6H |
6830 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 169 |
EIF4B |
1975 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 170 |
CLTA |
1211 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 171 |
LIMD1 |
8994 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 172 |
SH3GL2 |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 173 |
TXNIP |
10628 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 174 |
FLYWCH2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 175 |
ADRM1 |
11047 |
| Co-fractionation |
|
Homo sapiens |
|
| 176 |
MAP1A |
4130 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 177 |
HNRNPL |
3191 |
| Co-fractionation |
|
Homo sapiens |
|
| 178 |
MAST1 |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 179 |
GAPVD1 |
26130 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 180 |
SPTBN1 |
6711 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 181 |
HSPA1B |
3304 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 182 |
ZSWIM7 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 183 |
POC5 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 184 |
EDRF1 |
|
| Proximity Label-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 185 |
PTPRF |
5792 |
| Two-hybrid |
|
Homo sapiens |
|
| 186 |
TLE1 |
7088 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 187 |
ACOT7 |
11332 |
| Co-fractionation |
|
Homo sapiens |
|
| 188 |
SMC3 |
9126 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 189 |
NCBP1 |
4686 |
| Co-fractionation |
|
Homo sapiens |
|
| 190 |
SPRTN |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 191 |
DPH2 |
1802 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 192 |
HMCES |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 193 |
GART |
2618 |
| Co-fractionation |
|
Homo sapiens |
|
| 194 |
HSPA6 |
3310 |
| Co-fractionation |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 195 |
GJA1 |
2697 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 196 |
PI4KB |
5298 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 197 |
ARFGAP2 |
84364 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 198 |
NACA |
4666 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 199 |
ADRB2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 200 |
QKI |
9444 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 201 |
PACSIN2 |
11252 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 202 |
CORO7 |
79585 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 203 |
HSP90AB1 |
3326 |
| Co-fractionation |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 204 |
CAND1 |
55832 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 205 |
SRSF2 |
6427 |
| Co-fractionation |
|
Homo sapiens |
|
| 206 |
KIAA1598 |
57698 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 207 |
DNAJB6 |
10049 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 208 |
LGALS3BP |
3959 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 209 |
RPS9 |
6203 |
| Co-fractionation |
|
Homo sapiens |
|
| 210 |
WTAP |
9589 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 211 |
NCOR1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 212 |
ARMC2 |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 213 |
HSPA2 |
3306 |
| Co-fractionation |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 214 |
DPYSL2 |
1808 |
| Co-fractionation |
|
Homo sapiens |
|
| 215 |
COPS6 |
10980 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 216 |
TLN1 |
7094 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 217 |
TNIK |
23043 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 218 |
SRRM2 |
23524 |
| Affinity Capture-MS |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
|
| 219 |
PPP6R1 |
22870 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 220 |
RECQL4 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 221 |
WASH1 |
100287171 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 222 |
C6orf106 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 223 |
STIP1 |
10963 |
| Co-fractionation |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Proximity Label-MS |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 224 |
ELP4 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 225 |
DNAJC7 |
7266 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 226 |
VCAM1 |
7412 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 227 |
PALLD |
23022 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 228 |
MYL12A |
10627 |
| Co-fractionation |
|
Homo sapiens |
|
| 229 |
CUL1 |
8454 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 230 |
POLR2M |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 231 |
KNSTRN |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 232 |
ERCC6L |
54821 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 233 |
LMAN1 |
3998 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 234 |
STAM2 |
10254 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 235 |
VRK3 |
51231 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 236 |
R3HDM1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 237 |
DNAJB8 |
165721 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 238 |
USP10 |
9100 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 239 |
NFRKB |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 240 |
RBX1 |
9978 |
| Affinity Capture-MS |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
|
| 241 |
MOB4 |
25843 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 242 |
CDKN1A |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 243 |
RNASEH2A |
10535 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 244 |
KLC1 |
3831 |
| Co-fractionation |
|
Homo sapiens |
|
| 245 |
CCDC88C |
440193 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 246 |
MSX2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 247 |
SLC2A8 |
29988 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 248 |
PRAM1 |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 249 |
PSMD14 |
10213 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 250 |
BAG6 |
7917 |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 251 |
AHNAK |
79026 |
| Co-fractionation |
|
Homo sapiens |
|
| 252 |
CFDP1 |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 253 |
CCNB1 |
891 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 254 |
MB21D2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 255 |
HDGFRP3 |
50810 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 256 |
RAD18 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 257 |
APMAP |
57136 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 258 |
HEMGN |
|
| Two-hybrid |
|
Homo sapiens |
|
| 259 |
NCL |
4691 |
| Co-fractionation |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 260 |
PATL1 |
219988 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 261 |
ASB10 |
|
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 262 |
DSP |
1832 |
| Co-fractionation |
|
Homo sapiens |
|
| 263 |
Bag2 |
|
| Affinity Capture-MS |
|
Mus musculus |
|
| 264 |
CRISP3 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 265 |
MZT2A |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 266 |
MAGOH |
4116 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 267 |
RPLP0 |
6175 |
| Co-fractionation |
|
Homo sapiens |
|
| 268 |
UPK1A |
11045 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 269 |
TMEM131 |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 270 |
NFX1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 271 |
UBXN6 |
80700 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 272 |
TANC1 |
85461 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 273 |
FBXL4 |
26235 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 274 |
HNRNPD |
3184 |
| Co-fractionation |
|
Homo sapiens |
|
| 275 |
PTPN11 |
5781 |
| Co-fractionation |
|
Homo sapiens |
|
| 276 |
TUBB |
203068 |
| Co-fractionation |
|
Homo sapiens |
|
| 277 |
ACLY |
47 |
| Co-fractionation |
|
Homo sapiens |
|
| 278 |
AIFM1 |
9131 |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 279 |
EIF6 |
3692 |
| Co-fractionation |
|
Homo sapiens |
|
| 280 |
RC3H2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 281 |
UBAP2 |
55833 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 282 |
LUZP1 |
7798 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 283 |
TBCE |
6905 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 284 |
PITHD1 |
57095 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 285 |
PPA1 |
5464 |
| Co-fractionation |
|
Homo sapiens |
|
| 286 |
PRKAR2A |
5576 |
| Co-fractionation |
|
Homo sapiens |
|
| 287 |
C1orf52 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 288 |
DAPP1 |
27071 |
| Two-hybrid |
|
Homo sapiens |
|
| 289 |
EGFR |
1956 |
| PCA |
|
Homo sapiens |
| Two-hybrid |
|
Homo sapiens |
| PCA |
|
Homo sapiens |
| Affinity Capture-Luminescence |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 290 |
PACSIN3 |
29763 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 291 |
PRUNE |
58497 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 292 |
FAM195A |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 293 |
ATXN2 |
6311 |
| Co-fractionation |
|
Homo sapiens |
|
| 294 |
ZNF503 |
84858 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 295 |
ARFIP1 |
27236 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 296 |
SCYL2 |
55681 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 297 |
SMAP1 |
60682 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 298 |
CEP250 |
11190 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 299 |
CER1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 300 |
RAPGEF2 |
9693 |
| Two-hybrid |
|
Homo sapiens |
|
| 301 |
MYC |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 302 |
UBASH3A |
53347 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 303 |
PTGES3 |
10728 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 304 |
HNRNPAB |
3182 |
| Co-fractionation |
|
Homo sapiens |
|
| 305 |
MYBBP1A |
10514 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 306 |
DDRGK1 |
65992 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 307 |
BMI1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 308 |
LRCH2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 309 |
HMG20A |
|
| Co-fractionation |
|
Homo sapiens |
|
| 310 |
ADAR |
103 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 311 |
MYSM1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 312 |
PABPC4 |
8761 |
| Co-fractionation |
|
Homo sapiens |
|
| 313 |
C9orf84 |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 314 |
HUWE1 |
10075 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 315 |
TACC3 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 316 |
SYNRG |
11276 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 317 |
LARS |
51520 |
| Co-fractionation |
|
Homo sapiens |
|
| 318 |
TRIM38 |
10475 |
| Two-hybrid |
|
Homo sapiens |
|
| 319 |
MAP2K2 |
5605 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 320 |
CEP290 |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 321 |
RRM2 |
6241 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 322 |
C21orf59 |
56683 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 323 |
TTC1 |
7265 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 324 |
PARP1 |
142 |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 325 |
ILF3 |
3609 |
| Co-fractionation |
|
Homo sapiens |
|
| 326 |
TP53 |
7157 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 327 |
SLK |
9748 |
| Affinity Capture-MS |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 328 |
RTN3 |
10313 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 329 |
HLTF |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 330 |
TDRD7 |
23424 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 331 |
CCDC117 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 332 |
OXSR1 |
9943 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 333 |
ILDR1 |
286676 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 334 |
CENPF |
1063 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 335 |
PSME3 |
10197 |
| Co-fractionation |
|
Homo sapiens |
|
| 336 |
FAM83F |
113828 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 337 |
RNF20 |
56254 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 338 |
OTUB1 |
55611 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 339 |
DNAJC12 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 340 |
MAP2K1 |
5604 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 341 |
NAV3 |
89795 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 342 |
AHCYL2 |
23382 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 343 |
ABI2 |
10152 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 344 |
HSPBP1 |
23640 |
| Affinity Capture-Luminescence |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Proximity Label-MS |
|
Homo sapiens |
|
| 345 |
CDV3 |
55573 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 346 |
QRICH1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 347 |
ERRFI1 |
54206 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 348 |
C16orf72 |
29035 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 349 |
DNAJB4 |
11080 |
| Affinity Capture-Western |
|
Homo sapiens |
| Protein-peptide |
|
Homo sapiens |
|
| 350 |
PRKCA |
5578 |
| Co-fractionation |
|
Homo sapiens |
|
| 351 |
PRDX1 |
5052 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 352 |
PUM1 |
9698 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 353 |
DKC1 |
1736 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 354 |
SKA3 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 355 |
AKT1S1 |
84335 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 356 |
CYCS |
54205 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 357 |
PPP2R1A |
5518 |
| Affinity Capture-MS |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
|
| 358 |
PRMT1 |
3276 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 359 |
NUP50 |
10762 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 360 |
BCL7A |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 361 |
RCOR1 |
|
| Co-fractionation |
|
Homo sapiens |
|
| 362 |
CUL4A |
8451 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 363 |
CC2D1A |
54862 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 364 |
PLCD4 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 365 |
HNRNPC |
3183 |
| Co-fractionation |
|
Homo sapiens |
|
| 366 |
RHOF |
54509 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 367 |
SNCB |
6620 |
| FRET |
|
Homo sapiens |
|
| 368 |
CBX1 |
10951 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 369 |
GMNN |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 370 |
TCEB1 |
6921 |
| Co-fractionation |
|
Homo sapiens |
|
| 371 |
USP43 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 372 |
CENPE |
1062 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 373 |
DENR |
8562 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 374 |
TPD52L2 |
7165 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 375 |
ANKK1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 376 |
MME |
4311 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 377 |
DNAJA4 |
55466 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 378 |
ABCF1 |
23 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 379 |
PAK2 |
5062 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 380 |
EPS15 |
2060 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 381 |
ANK1 |
286 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 382 |
BUB1B |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 383 |
C1orf198 |
84886 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 384 |
SEMG2 |
6407 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 385 |
PGR |
|
| Reconstituted Complex |
|
Homo sapiens |
|
| 386 |
HNRNPR |
10236 |
| Co-fractionation |
|
Homo sapiens |
|
| 387 |
PSMD10 |
5716 |
| Co-fractionation |
|
Homo sapiens |
|
| 388 |
SOX9 |
|
| Affinity Capture-Western |
|
Homo sapiens |
|
| 389 |
RPS6KB2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 390 |
HSF2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 391 |
ANKRD17 |
26057 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 392 |
RYR1 |
6261 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 393 |
SART3 |
9733 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 394 |
CTBP1 |
1487 |
| Co-fractionation |
|
Homo sapiens |
|
| 395 |
MCM2 |
4171 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 396 |
IARS |
3376 |
| Co-fractionation |
|
Homo sapiens |
|
| 397 |
RASAL2 |
9462 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 398 |
ARHGAP1 |
392 |
| Co-fractionation |
|
Homo sapiens |
|
| 399 |
LIG1 |
3978 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 400 |
LASP1 |
3927 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 401 |
COL8A1 |
1295 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 402 |
QARS |
5859 |
| Co-fractionation |
|
Homo sapiens |
|
| 403 |
DMD |
1756 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 404 |
TAB2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 405 |
HNRNPU |
3192 |
| Co-fractionation |
|
Homo sapiens |
|
| 406 |
DLL3 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 407 |
BCORL1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 408 |
ITGA4 |
3676 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 409 |
GOLGA4 |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 410 |
RPS3A |
6189 |
| Co-fractionation |
|
Homo sapiens |
|
| 411 |
TFCP2 |
7024 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 412 |
N4BP2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 413 |
DPH1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 414 |
TMTC3 |
160418 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 415 |
HSPA8 |
3312 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 416 |
INSIG2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 417 |
BSG |
682 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 418 |
UBR4 |
23352 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 419 |
EIF2AK2 |
5610 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 420 |
S100A2 |
6273 |
| Co-fractionation |
|
Homo sapiens |
|
| 421 |
ATP5A1 |
498 |
| Co-fractionation |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
|
| 422 |
P4HA1 |
5033 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 423 |
NEB |
4703 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 424 |
PRPH |
5630 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 425 |
CUL4B |
8450 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 426 |
PARK2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Reconstituted Complex |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 427 |
RPS10 |
6204 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 428 |
HDAC1 |
3065 |
| Co-fractionation |
|
Homo sapiens |
|
| 429 |
MARS |
4141 |
| Co-fractionation |
|
Homo sapiens |
|
| 430 |
TUBGCP4 |
27229 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 431 |
GNAT2 |
2780 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 432 |
PCDHA1 |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 433 |
CAST |
831 |
| Co-fractionation |
|
Homo sapiens |
|
| 434 |
AMOT |
154796 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 435 |
RTF1 |
23168 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 436 |
DNAJC5 |
80331 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 437 |
ABCF2 |
10061 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 438 |
MAPT |
|
| Affinity Capture-Western |
|
Homo sapiens |
| Reconstituted Complex |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 439 |
LDB3 |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 440 |
RAN |
5901 |
| Co-fractionation |
|
Homo sapiens |
|
| 441 |
NTRK1 |
4914 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 442 |
DHX9 |
1660 |
| Co-fractionation |
|
Homo sapiens |
|
| 443 |
METTL21A |
|
| Biochemical Activity |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 444 |
ARNT |
405 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 445 |
DNAJA1 |
3301 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 446 |
ARMC1 |
55156 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 447 |
FLNB |
2317 |
| Co-fractionation |
|
Homo sapiens |
|
| 448 |
RPA4 |
|
| Proximity Label-MS |
|
Homo sapiens |
|
| 449 |
ACTB |
60 |
| Co-fractionation |
|
Homo sapiens |
|
| 450 |
UBE2D3 |
7323 |
| Biochemical Activity |
|
Homo sapiens |
| Reconstituted Complex |
|
Homo sapiens |
|
| 451 |
YAP1 |
10413 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 452 |
HDAC5 |
10014 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 453 |
KIF20B |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 454 |
HMGB2 |
3148 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 455 |
ENDOG |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 456 |
CBFB |
865 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 457 |
TTN |
7273 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 458 |
HNRNPDL |
9987 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 459 |
SLX4 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 460 |
ZAK |
51776 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 461 |
KMT2A |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 462 |
METTL14 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 463 |
DNAJB12 |
54788 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 464 |
CSTF2T |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 465 |
BAG2 |
9532 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 466 |
TRAF3IP1 |
26146 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 467 |
EEF2 |
1938 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
|
| 468 |
PSMD6 |
9861 |
| Co-fractionation |
|
Homo sapiens |
|
| 469 |
U2AF2 |
11338 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 470 |
SIRPA |
140885 |
| Reconstituted Complex |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 471 |
HYPK |
25764 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 472 |
RPRD2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 473 |
ENDOD1 |
23052 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 474 |
NR3C1 |
2908 |
| Reconstituted Complex |
|
Homo sapiens |
|
| 475 |
ATXN10 |
25814 |
| Co-fractionation |
|
Homo sapiens |
|
| 476 |
FBXO6 |
26270 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 477 |
MAP1B |
4131 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 478 |
MAT2A |
4144 |
| Co-fractionation |
|
Homo sapiens |
|
| 479 |
MAP3K7 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 480 |
AP2M1 |
1173 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 481 |
ASB16 |
92591 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 482 |
MSR1 |
|
| Affinity Capture-Western |
|
Homo sapiens |
| Reconstituted Complex |
|
Homo sapiens |
|
| 483 |
PRPF19 |
27339 |
| Co-fractionation |
|
Homo sapiens |
|
| 484 |
KIF11 |
3832 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 485 |
PPWD1 |
23398 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 486 |
PPP6C |
5537 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 487 |
PTPN23 |
25930 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 488 |
KIAA1671 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 489 |
NSRP1 |
|
| Co-fractionation |
|
Homo sapiens |
|
| 490 |
KIAA0368 |
23392 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 491 |
CD96 |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 492 |
HSPD1 |
3329 |
| Co-fractionation |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
|
| 493 |
LRRC40 |
55631 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 494 |
NEUROG3 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 495 |
AKAP1 |
8165 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 496 |
SETSIP |
646817 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 497 |
XRCC5 |
7520 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 498 |
ACBD5 |
91452 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 499 |
VPS25 |
84313 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 500 |
TBX3 |
6926 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 501 |
AHSA1 |
10598 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 502 |
VWCE |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 503 |
FNBP4 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 504 |
PLEKHA4 |
57664 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 505 |
ALDOC |
230 |
| Co-fractionation |
|
Homo sapiens |
|
| 506 |
GMFB |
2764 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 507 |
RPS25 |
6230 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 508 |
MAX |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 509 |
RPS3 |
6188 |
| Co-fractionation |
|
Homo sapiens |
|
| 510 |
FBXL6 |
|
| Affinity Capture-Western |
|
Homo sapiens |
|
| 511 |
FANCC |
2176 |
| Affinity Capture-Western |
|
Homo sapiens |
| Two-hybrid |
|
Homo sapiens |
|
| 512 |
TTC28 |
23331 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 513 |
MCM5 |
4174 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 514 |
RNF31 |
55072 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 515 |
PRRC2C |
23215 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 516 |
CEP72 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 517 |
ALDH1B1 |
219 |
| Co-fractionation |
|
Homo sapiens |
|
| 518 |
IKBKG |
8517 |
| Reconstituted Complex |
|
Homo sapiens |
|
| 519 |
HSPB1 |
3315 |
| Co-fractionation |
|
Homo sapiens |
|
| 520 |
PLOD1 |
5351 |
| Co-fractionation |
|
Homo sapiens |
|
| 521 |
PRRC2B |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 522 |
OXR1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 523 |
TRIM25 |
7706 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 524 |
RAVER1 |
125950 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 525 |
UFL1 |
23376 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 526 |
MBNL1 |
4154 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 527 |
KDM1A |
23028 |
| Affinity Capture-MS |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
|
| 528 |
MED12 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 529 |
LRRK2 |
120892 |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 530 |
DNAJC5B |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 531 |
NEDD1 |
121441 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 532 |
SPAG1 |
6674 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 533 |
TCF20 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 534 |
HNRNPF |
3185 |
| Co-fractionation |
|
Homo sapiens |
|
| 535 |
RPRD1B |
58490 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 536 |
STK11 |
6794 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 537 |
SERBP1 |
26135 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 538 |
UHRF1 |
29128 |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 539 |
AR |
367 |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 540 |
KRTAP13-3 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 541 |
RC3H1 |
149041 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 542 |
UBA6 |
55236 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 543 |
ZNF318 |
24149 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 544 |
STAM |
8027 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 545 |
FCHSD1 |
89848 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 546 |
ATG3 |
64422 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 547 |
HNRNPA2B1 |
3181 |
| Co-fractionation |
|
Homo sapiens |
|
| 548 |
UBE2H |
7328 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 549 |
INSIG1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 550 |
C15orf39 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 551 |
OTUD5 |
55593 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 552 |
Myh3 |
|
| Affinity Capture-MS |
|
Mus musculus |
|
| 553 |
ABL2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 554 |
CUEDC2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 555 |
PAXIP1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 556 |
POT1 |
|
| Two-hybrid |
|
Homo sapiens |
|
| 557 |
DOCK4 |
9732 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 558 |
MKL1 |
57591 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 559 |
YTHDF1 |
54915 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 560 |
PSMD11 |
5717 |
| Co-fractionation |
|
Homo sapiens |
|
| 561 |
UBE2M |
9040 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 562 |
DST |
667 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 563 |
RNF25 |
64320 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 564 |
PBK |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 565 |
ARFGAP3 |
26286 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 566 |
HSPA1L |
3305 |
| Co-fractionation |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 567 |
TSG101 |
7251 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 568 |
TAB1 |
10454 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 569 |
KARS |
3735 |
| Co-fractionation |
|
Homo sapiens |
|
| 570 |
TROVE2 |
6738 |
| Co-fractionation |
|
Homo sapiens |
|
| 571 |
SMAP2 |
64744 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 572 |
ANKRD28 |
23243 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 573 |
BRWD1 |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 574 |
CNN3 |
1266 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 575 |
ILF2 |
3608 |
| Affinity Capture-MS |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
|
| 576 |
QSER1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 577 |
KIAA1429 |
25962 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 578 |
EIF4ENIF1 |
56478 |
| Two-hybrid |
|
Homo sapiens |
|
| 579 |
TOP2A |
7153 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 580 |
IRF2BP1 |
26145 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 581 |
PPP1R12A |
4659 |
| Co-fractionation |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 582 |
RPL24 |
6152 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 583 |
TGFB1 |
7040 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 584 |
JARID2 |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 585 |
KIF5B |
3799 |
| Co-fractionation |
|
Homo sapiens |
|
| 586 |
CASC5 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 587 |
COPS5 |
10987 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 588 |
FBXW7 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 589 |
UBA1 |
7317 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 590 |
HGS |
9146 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 591 |
YWHAG |
7532 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 592 |
TOM1L1 |
10040 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 593 |
MYO1B |
4430 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 594 |
DNAJC16 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 595 |
BRD4 |
23476 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 596 |
CEP57 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 597 |
TERT |
|
| Affinity Capture-Western |
|
Homo sapiens |
|
| 598 |
SPATA5L1 |
79029 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 599 |
PSMC6 |
5706 |
| Co-fractionation |
|
Homo sapiens |
|
| 600 |
CTTNBP2NL |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 601 |
ADSS |
159 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 602 |
HAUS4 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 603 |
DVL2 |
1856 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 604 |
LAMTOR1 |
55004 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 605 |
CCDC86 |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 606 |
STOML2 |
30968 |
| Co-fractionation |
|
Homo sapiens |
|
| 607 |
GARS |
2617 |
| Co-fractionation |
|
Homo sapiens |
|
| 608 |
ZNF217 |
7764 |
| Co-fractionation |
|
Homo sapiens |
|
| 609 |
HAUS2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 610 |
IKBIP |
121457 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 611 |
AGFG1 |
3267 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 612 |
EMD |
2010 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 613 |
TGM2 |
7052 |
| Two-hybrid |
|
Homo sapiens |
|
| 614 |
SRA1 |
10011 |
| Co-fractionation |
|
Homo sapiens |
|
| 615 |
ERBB3 |
2065 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 616 |
HMGN2 |
3151 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 617 |
HIVEP1 |
3096 |
| Two-hybrid |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 618 |
HSP90B1 |
7184 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 619 |
ZFC3H1 |
196441 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 620 |
NONO |
4841 |
| Co-fractionation |
|
Homo sapiens |
|
| 621 |
STAU1 |
6780 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 622 |
CPS1 |
1373 |
| Co-fractionation |
|
Homo sapiens |
|
| 623 |
MID1IP1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 624 |
SMARCA4 |
6597 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 625 |
ANKHD1 |
54882 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 626 |
VCP |
7415 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 627 |
SUMO2 |
6613 |
| Reconstituted Complex |
|
Homo sapiens |
|
| 628 |
DCTN1 |
1639 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 629 |
UBFD1 |
56061 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 630 |
FH |
2271 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 631 |
CRY2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 632 |
BECN1 |
8678 |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 633 |
DDX1 |
1653 |
| Co-fractionation |
|
Homo sapiens |
|
| 634 |
EIF4G2 |
1982 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 635 |
BRAF |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 636 |
AP3B1 |
8546 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 637 |
ATP2B4 |
493 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 638 |
CEP76 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 639 |
PHACTR4 |
65979 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 640 |
DNAJB5 |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 641 |
MZT2B |
80097 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 642 |
ST13 |
6767 |
| Reconstituted Complex |
|
Homo sapiens |
| Proximity Label-MS |
|
Homo sapiens |
|
| 643 |
LRRC8A |
56262 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 644 |
BAG3 |
9531 |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 645 |
SRSF11 |
9295 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 646 |
NUMA1 |
4926 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 647 |
GAN |
8139 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 648 |
SLC25A24 |
29957 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 649 |
AIRE |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 650 |
FANCD2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 651 |
SF1 |
7536 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 652 |
EIF4G1 |
1981 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 653 |
PSMD13 |
5719 |
| Co-fractionation |
|
Homo sapiens |
|
| 654 |
LETM1 |
3954 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 655 |
NAT10 |
55226 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 656 |
RLIM |
51132 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 657 |
ASAP3 |
55616 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 658 |
PDIA3 |
2923 |
| Co-fractionation |
|
Homo sapiens |
|
| 659 |
SEPT11 |
55752 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 660 |
BAP1 |
8314 |
| Co-purification |
|
Homo sapiens |
|
| 661 |
PYCR2 |
29920 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 662 |
RPL7 |
6129 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 663 |
SUZ12 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 664 |
AURKB |
9212 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 665 |
PSTPIP1 |
9051 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 666 |
AGO4 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 667 |
MYO15A |
51168 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 668 |
DCUN1D1 |
54165 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 669 |
FOS |
2353 |
| Reconstituted Complex |
|
Homo sapiens |
|
| 670 |
HNRNPA1 |
3178 |
| Affinity Capture-MS |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
|
| 671 |
EPN1 |
29924 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 672 |
RREB1 |
6239 |
| Co-fractionation |
|
Homo sapiens |
|
| 673 |
DYRK2 |
8445 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 674 |
CLTC |
1213 |
| Affinity Capture-MS |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Proximity Label-MS |
|
Homo sapiens |
|
| | |